The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
HIG Capital has agreed to sell BioVectra, a biotechnology and pharmaceutical contract development and manufacturing organization (CDMO), to Agilent Technologies for $925 million. The acquisition ...
After changing hands several times throughout the 2010s, Canadian specialty contract development and manufacturing organization (CDMO) Biovectra has agreed to fly the Agilent flag. In turn, Agilent ...
H.I.G. Capital has closed its previously announced acquisition of BioVectra Inc, a contract development and manufacturing organization of active pharmaceutical ingredients and intermediates. No ...
PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, and ...
BIOVECTRA, a part of Agilent Technologies Inc., and Revolution Biomanufacturing Inc. today announced a collaboration that grants BIOVECTRA access to Revolution Biomanufacturing's proprietary platforms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results